Management of Clinical Trials (2021)
|University of Geneva|
|Location||Geneva, Lake Geneva region, Switzerland|
DAS Registration 2022-2023
Registration for the next edition of the DAS 2022-2023 will be open in spring 2022. Those interested can already contact the DAS programme coordination at for more information.
For individual modules, application should be sent at least one month prior to the beginning of the selected module (2 to 12). Priority will be given to candidates applying for the Diploma.
Medical doctor, biologist, pharmacist, nurse, biochemist and other professional involved, or wishing to gain skills and knowledge in the field of clinical research
Prof. Jules DESMEULES and Dr François CURTIN, Faculty of Science and Faculty of Medicine, University of Geneva
The course is accredited by Swissethics, Swiss Association of Pharmaceutical Professionals (SwAPP), Swiss Society of Clinical Pharmacology and Toxicology (SGKPT-SSPTC), Swiss Institute for postgraduate and continuous medical education (SWIF-ISFM)
Dissertation : students may choose between vocational training in a pharmaceutical company, a Clinical Research Organization (CRO) or a Clinical Trial Unit in a University Hospital (320 hours over 3-4 months) or the development of a Clinical Trial protocol or a literature review and dissertation (320 hours).
Good Clinical Practice implementation and quality processes provide a theoretical and practical understanding of how these principles are shaping each step of a Clinical Trial, including study design, trial management and conduct.
Candidates who follow the programme during their working time must provide written authorization from their employer.
Prof. Gerrit Borchard, Head of Biopharmaceutics, Section of Pharmaceutical Sciences, Faculty of Science, University of Geneva Prof. Cem Gabay, Dean of the Faculty of Medicine, University of Geneva Prof. Bernard Hirschel, President, Cantonal Commission on Human Research Ethics, Canton of Geneva Prof. Samia Hurst, Director, Institute of Ethics, History and Humanities (iEH2), Faculty of Medicine, University of Geneva Prof. Angèle Gayet-Ageron, Head of the Methodological Support Unit, Clinical Research Centre (CRC), University Hospitals of Geneva, Faculty of Medecine, University of Geneva Prof. Arnaud Perrier, Medical Director, University Hospitals of Geneva Prof. Jérôme Pugin, Vice-Dean of the Faculty of Medicine and President of the Clinical Research Center (CRC), University Hospitals of Geneva, Faculty of Medicine, University of Geneva
Dr Gabriele Ackermann, Chief Scientific Officer ad interim, Therapeutic Area Head Cardiovascular, Renal & Metabolism Therapeutic Area Head Respiratory, Novartis Pharma Switzerland Dr Emilie Alirol, Medicines for Malaria Venture, Associate Director, Access and Product Management Dr Enrica Alteri, Pharmaceutical consultant, former Head of Human Medicine R&D Support Division, EMA Dr Vanya Beltrami, Vice-President, Head of Manufacturing, Anergis, Lausanne Dr Jocelyne Chabert, Clinical Research Associate, Clinical Research Centre (CRC), University Hospitals of Geneva, Faculty of Medicine, University of Geneva Dr Francois Curtin PD, Medical Director Personalised Health Programmes, Swiss Federal Institute of Technology in Zürich & Lecturer at Hospitals of Geneva (UNIGE) Prof. Youssef Daali, Head of the laboratory of the Division of Clinical Pharmacology and Toxicology, University Hospitals of Geneva, Faculty of Medicine, University of Geneva Dr Patricia Delaite, Chief Medical Officer, Nouscom, Basel Dr Catherine Deloche, Chief Operating Officer, Solid Drug Development, Geneva Prof. Philippe Ducor, Faculty of Law, University of Geneva Prof. Marc Froissart, Medical Director of the Clinical Research Centre (CRC), CHUV-UNIL, Lausanne Prof. Angèle Gayet-Ageron, Head of the Methodological Support Unit, Clinical Research Centre (CRC), University Hospitals of Geneva, Faculty of Medecine, University of Geneva Dr Françoise Lascombes, External Consultant Prof. Hervé Porchet, Pharmaceutical consultant Dr Victoria Rollason, Division of Clinical Pharmacology and Toxicology, University Hospitals of Geneva and Faculty of Medicine, University of Geneva
Candidates are warned that a significant amount of self-study is required to complete the DAS, and that they are expected to go through preparatory work before each module. Students should thus allow sufficient time to study at home, in addition to attending the classroom lectures.
Les termes utilisés pour désigner des personnes sont pris au sens générique; ils ont à la fois la valeur d’un masculin et d’un féminin.
In your contacts, please refer to myScience.ch
and reference edu.myScience.ch/id1524
Related Job Offers
- 01.07.22 - Post-Doc (m/w/d) im Bereich Zirkuläre Wertschöpfung - Köln
- 01.07.22 - Postdoc position in the cognitive neuroscience of memory - Bern
- 24.06.22 - Verantwortliche/r Forschung - St. Gallen
- 20.06.22 - Wissenschaftliche/r Mitarbeiter/in Sektion Analysen, Mittel und Gegenstände - Köniz-Liebefeld
- 17.06.22 - PostDoc-Stelle - NRL Antibiotikaresistenz - Graz
- 13.06.22 - Postdoctoral Researcher (gn*) - Münster
- 10.06.22 - PROFESSOR in PHARMACEUTICAL ANALYSIS (Full, Associate, or Assistant tenure track) - Genève 4
- 07.06.22 - Associate Professor in Health Inequalities and Social Policy - Esch-sur-Alzette
- 01.06.22 - Leiter/in Sektion Prävention und Promotion - Bern-Liebefeld
1 July 2022
New Diagnosis for Post-Traumatic Stress Disorder
» More news